The relationship between MUC1, MUC4, MUC16 molecules and treg cells and epithelial-mesenchymal transmission in pancreatic cancer

被引:0
|
作者
Gocer, Isinsu Melis [1 ]
Ozgun, Gonca [2 ]
Ozdemir, Handan [2 ]
Ozmen, Fusun [1 ]
机构
[1] Hacettepe Univ, Dept Basic Oncol, Inst Canc, Ankara, Turkey
[2] Baskent Univ, Dept Med Pathol, Sch Med, Ankara, Turkey
关键词
Cancer immunology; immune communication; molecular immunology; regulatory cells;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P-0319
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [31] Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance
    Sierzega, Marek
    Mlynarski, Damian
    Tomaszewska, Romana
    Kulig, Jan
    HISTOPATHOLOGY, 2016, 69 (04) : 582 - 591
  • [32] TET1 was an important factor for DNA demethylation to regulate the expression of MUC1 and MUC4 in lung cancer
    Yokoyama, S.
    Kitamoto, S.
    Higashi, M.
    Tsutsumida, H.
    Wakimoto, J.
    Yonezawa, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S98 - S99
  • [33] The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer
    Curry, Jennifer M.
    Thompson, Kyle J.
    Rao, Shanti G.
    Besmer, Dahlia M.
    Murphy, Andrea M.
    Grdzelishvili, Valery Z.
    Ahrens, William A.
    McKillop, Iain H.
    Sindram, David
    Iannitti, David A.
    Martinie, John B.
    Mukherjee, Pinku
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (07) : 713 - 722
  • [34] Evaluation of clinico-pathological prognostic factors, and prognostic significance of MUC1 and MUC4 molecules in pulmonary pleomorphic carcinoma
    Kwon, K.
    Choi, W.
    Park, J.
    Jung, H.
    Kwon, S.
    Choi, M.
    Kang, Y.
    Kim, S.
    Lee, S.
    HISTOPATHOLOGY, 2008, 53 : 352 - 353
  • [35] Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
    Williams, Kristina A.
    Terry, Kathryn L.
    Tworoger, Shelley S.
    Vitonis, Allison F.
    Titus, Linda J.
    Cramer, Daniel W.
    PLOS ONE, 2014, 9 (02):
  • [36] Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
    Bafna, S.
    Kaur, S.
    Momi, N.
    Batra, S. K.
    BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1155 - 1161
  • [37] MUC4 induces Epithelial Mesenchymal Transition Through N-Cadherin Upregulation in Pancreatic Cancer
    Rachagani, S.
    Macha, M. A.
    Ponnusamy, M. P.
    Chakraborty, S.
    Batra, S. K.
    PANCREAS, 2011, 40 (08) : 1350 - 1350
  • [38] Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours
    Westgaard, Arne
    Schjolberg, Aasa R.
    Cvancarova, Milada
    Eide, Tor J.
    Clausen, Ole Petter F.
    Gladhaug, Ivar P.
    HISTOPATHOLOGY, 2009, 54 (03) : 337 - 347
  • [39] Downregulation of MUC4 in pancreatic cancer cells by thymoquinone: A promise for pancreatic cancer therapies
    Torres, Maria P.
    Ponnusamy, Moorthy P.
    Chakraborty, Subhankar
    Arafat, Hwyda A.
    Batra, Surinder K.
    CANCER RESEARCH, 2010, 70
  • [40] Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
    S Bafna
    S Kaur
    N Momi
    S K Batra
    British Journal of Cancer, 2009, 101 : 1155 - 1161